aripiprazole parenteral; aripiprazole lauroxil (Aristada)
Jump to navigation
Jump to search
Indications
- treatment of adults with schizophrenia
Dosage
- IM injection every 4-6 weeks into the arm or buttocks
Adverse effects
- akasthesia (most common)
- drug adverse effects of antipsychotic agents
- drug adverse effects of atypical antipsychotic agents
- drug adverse effects of psychotropic agents
More general terms
References
- ↑ FDA News Release. Oct 6, 2015 FDA approves new injectable drug to treat schizophrenia. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465801.htm